Reversal Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Reversal Therapeutics, Inc. - overview
Established
2023
Location
Maryland, MD, US
Primary Industry
Healthcare
About
Based in Maryland, US, and founded in 2023 by co-founder Lyle Isaacs, Reversal Therapeutics, Inc. operates as a developer of therapies for various medical conditions. In August 2024, Reversal Therapeutics, Inc. raised venture funding from Maryland Venture Fund.
Reversal Therapeutics, Inc. develops therapeutic treatments for drug misuse and addiction in patients. The company specializes in pre-clinical biotechnology solutions for commercializing molecule with a variety of clinical benefits.
Current Investors
Maryland Technology Development Corporation
Primary Industry
Healthcare
Sub Industries
Alternative Medicine
Website
www.reversaltherapeutics.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.